Cite
Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).
MLA
Sainz, Empar, et al. “Clinical Features, Therapeutic Requirements and Evolution of Patients with Crohn’s Disease and Upper Gastrointestinal Involvement (CROHNEX Study).” Alimentary Pharmacology & Therapeutics, vol. 54, no. 8, Oct. 2021, pp. 1041–51. EBSCOhost, https://doi.org/10.1111/apt.16547.
APA
Sainz, E., Zabana, Y., Miguel, I., Fernández, C. A., Beltrán, B., Núñez, L., García, M. J., Martín, A. M. D., Iglesias, E., Cañete, F., Gutiérrez, A., Piqueras, M., Pérez, M. I., Bujanda, L., Rodríguez, L. I., Casanova, M. J., Navarro, P., Vicente, R., Merino, O., & Algaba, A. (2021). Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper gastrointestinal involvement (CROHNEX study). Alimentary Pharmacology & Therapeutics, 54(8), 1041–1051. https://doi.org/10.1111/apt.16547
Chicago
Sainz, Empar, Yamile Zabana, Isabel Miguel, Clotet, Agnès Fernández, Belén Beltrán, Laura Núñez, María José García, et al. 2021. “Clinical Features, Therapeutic Requirements and Evolution of Patients with Crohn’s Disease and Upper Gastrointestinal Involvement (CROHNEX Study).” Alimentary Pharmacology & Therapeutics 54 (8): 1041–51. doi:10.1111/apt.16547.